Europital launches as a science-driven full-service CRO
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries.
Europital, a globally focused full-service CRO serving small and mid-tier innovators, has launched new capabilities across project management, clinical monitoring, biostatistics, pharmacovigilance, regulatory affairs and data management, in addition to its existing medical affairs and medical writing services.
The expanded clinical research offering will see Europital support clients in more than 40 countries from investigational new drug (IND) through to commercial launch.
Dr Mohamed El Malt, Chief Medical Officer of Europita, said: “It’s no secret, there is a large gap in the CRO industry for these small innovators; what they need is a science-driven CRO that will support them closely with an experienced senior team but combined with a global trial network."
Europital has regional offices in Belgium, Hungary and the UK, with customers based in Europe and the US. Innovators developing therapies for oncology, infectious diseases, inflammatory and autoimmune diseases will be the major beneficiaries of the company's multifunctional and operational capabilities.
Sponsors who will particularly benefit are those that require a full range of CRO services for complex molecules and trial designs that necessitate senior medical and scientific oversight.
In addition to its regional offices in Europe, Europital has built a global network of trusted partners during the last 10 years with local operational expertise and preferential supply trial site agreements in the US, Canada, Russia, India, the Middle East and North Africa and Australia.
Dr El Malt explained that the decision to launch as a full-service CRO reflects the many requests it received from its clients to work on additional aspects of their clinical trials, the services for which they did not have in-house. Now, with the expansion, the company can provide a 360-degree CRO service to innovators in the pharmaceutical, biotechnology and medical devices sectors.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance